NurExone competed in the Healthcare category at the BOLD Awards VII, standing out among seven other leading companies in the field. The selection was made by a panel of judges composed of global market leaders, innovators, and change-makers. The principal judge for the Healthcare category was Mr. Ben Beckley, CEO of RevHealth. Ben works closely with caregivers, patients, and medical specialists to make a meaningful impact. Ben strives to transform care into tangible results and inspire the next generation of leaders in healthcare.
Dr. Lior Shaltiel, Chief Executive Officer of NurExone, commented, “We are pleased to have received first place in the Healthcare category at the BOLD Awards VII Gala in Barcelona, which reflects recognition of our team and our work in regenerative medicine. We are also pleased to engage IBN as we continue to expand awareness of NurExone’s progress and long-term vision.”